ISOPHANE INSULIN HUMAN MONOCOMPONENT

Isophane insulin human monocomponent is a form of insulin that is used to manage blood glucose levels in patients with diabetes. It is an intermediate-acting insulin, often called NPH insulin, and is derived from human insulin. This type of insulin has an onset of action within 1-2 hours, a peak effect at around 4-12 hours, and a duration of approximately 14-24 hours. It is commonly used in conjunction with other types of insulin for optimal blood sugar control.

Indications

Management of diabetes mellitus in both type 1 and type 2 diabetes. May be used as part of a combination therapy with other insulins or oral antidiabetic agents.

Dosage

-Dosage must be individualized based on the patient's needs, glucose monitoring results, and goals of therapy. -Typically injected subcutaneously into areas such as the thigh, upper arm, or abdomen. -Always follow the healthcare provider's instructions on dosage, frequency, and injection techniques.

Contra-Indications

Known hypersensitivity to isophane insulin or any of the product's components. Hypoglycemia, as it can worsen the condition.

Special Precautions

-Monitor blood glucose regularly to adjust the dose accordingly. -Avoid sudden changes in diet or physical activity as these can impact blood glucose control. -Be cautious in patients with renal or hepatic impairment. -Inform healthcare providers of other medications being taken, as they may interact with insulin. -Caution in pregnant or breastfeeding women; insulin requirements may change during these periods.

Side Effects

-Hypoglycemia (low blood sugar): the most common side effect. -Allergic reactions, including local reactions at the injection site such as redness, swelling, or itching. -Weight gain may occur with long-term use.

Drug Interactions

-Certain medications can interact with isophane insulin, affecting blood sugar levels. These include: Oral antidiabetic drugs Steroids Diuretics Beta-blockers Certain psychiatric medications Thyroid medications